LFMD LifeMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFMD

Price (delayed)

$3.05

Market cap

$147.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$127.89M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 11
Relative Valuation: Rel. Valuation: 48
Relative Profitability: Rel. Profitability: 41

LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, ...

Highlights
The debt has dropped by 73% year-on-year and by 2.5% since the previous quarter
The gross profit has grown by 6% YoY
The EPS has plunged by 183% from the previous quarter but it has soared by 85% YoY
LifeMD's net income has surged by 102% YoY but it has shrunk by 96% QoQ
LifeMD's equity has decreased by 47% QoQ
Sector: Healthcare
Industry: Health Information Services
Peers: PHR PHUN

Key stats

What are the main financial stats of LFMD

LFMD stock price

How has the LifeMD stock price performed over time
Intraday
-7.58%
1 week
-4.98%
1 month
-7.85%
1 year
-51.74%
YTD
-10.56%
QTD
-26.15%

Financial performance

How have LifeMD's revenue and profit performed over time
Revenue
$204.48M
Gross profit
$179.84M
Operating income
-$19.13M
Net income
$201,011
Gross margin
87.9%
Net margin
0.1%
The net margin has surged by 102% year-on-year but it has dropped by 96% since the previous quarter
LifeMD's net income has surged by 102% YoY but it has shrunk by 96% QoQ
LFMD's operating income has plunged by 55% YoY and by 33% from the previous quarter
LFMD's operating margin has dropped by 52% year-on-year and by 34% since the previous quarter

Price vs fundamentals

How does LFMD's price correlate with its fundamentals

Growth

What is LifeMD's growth rate over time

Valuation

What is LifeMD stock price valuation
P/E
N/A
P/B
18.52
P/S
0.71
EV/EBIT
245.8
EV/EBITDA
12.31
EV/Sales
0.63
The EPS has plunged by 183% from the previous quarter but it has soared by 85% YoY
The P/B is 72% less than the last 4 quarters average of 72.2
LifeMD's equity has decreased by 47% QoQ
The P/S is 41% below the 5-year quarterly average of 1.3 and 23% below the last 4 quarters average of 1.0
The revenue has grown by 3.1% YoY

Efficiency

How efficient is LifeMD business performance
LifeMD's ROE has plunged by 190% from the previous quarter
The ROS has soared by 107% YoY but it has plunged by 91% from the previous quarter
LFMD's ROA has soared by 78% year-on-year

Dividends

What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFMD.

Financial health

How did LifeMD financials performed over time
LifeMD's total assets is 15% more than its total liabilities
LFMD's total liabilities is down by 29% year-on-year and by 6% since the previous quarter
LifeMD's total assets has decreased by 19% YoY and by 15% from the previous quarter
The debt is 24% smaller than the equity
LFMD's debt to equity has surged by 106% year-on-year and by 85% since the previous quarter
The debt has dropped by 73% year-on-year and by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.